426 related articles for article (PubMed ID: 20481648)
1. Multiple peaking phenomena in pharmacokinetic disposition.
Davies NM; Takemoto JK; Brocks DR; Yáñez JA
Clin Pharmacokinet; 2010 Jun; 49(6):351-77. PubMed ID: 20481648
[TBL] [Abstract][Full Text] [Related]
2. Enterohepatic circulation: physiological, pharmacokinetic and clinical implications.
Roberts MS; Magnusson BM; Burczynski FJ; Weiss M
Clin Pharmacokinet; 2002; 41(10):751-90. PubMed ID: 12162761
[TBL] [Abstract][Full Text] [Related]
3. The gut in the beaker: Missing the surfactants?
Wilson CG; Halbert GW; Mains J
Int J Pharm; 2016 Nov; 514(1):73-80. PubMed ID: 27863685
[TBL] [Abstract][Full Text] [Related]
4. Role of enterohepatic recirculation in drug disposition: cooperation and complications.
Malik MY; Jaiswal S; Sharma A; Shukla M; Lal J
Drug Metab Rev; 2016 May; 48(2):281-327. PubMed ID: 26987379
[TBL] [Abstract][Full Text] [Related]
5. In vivo methods for drug absorption - comparative physiologies, model selection, correlations with in vitro methods (IVIVC), and applications for formulation/API/excipient characterization including food effects.
Sjögren E; Abrahamsson B; Augustijns P; Becker D; Bolger MB; Brewster M; Brouwers J; Flanagan T; Harwood M; Heinen C; Holm R; Juretschke HP; Kubbinga M; Lindahl A; Lukacova V; Münster U; Neuhoff S; Nguyen MA; Peer Av; Reppas C; Hodjegan AR; Tannergren C; Weitschies W; Wilson C; Zane P; Lennernäs H; Langguth P
Eur J Pharm Sci; 2014 Jun; 57():99-151. PubMed ID: 24637348
[TBL] [Abstract][Full Text] [Related]
6. Population-Based PBPK Model for the Prediction of Time-Variant Bile Salt Disposition within GI Luminal Fluids.
Stamatopoulos K; Pathak SM; Marciani L; Turner DB
Mol Pharm; 2020 Apr; 17(4):1310-1323. PubMed ID: 32176503
[TBL] [Abstract][Full Text] [Related]
7. Flip-flop pharmacokinetics--delivering a reversal of disposition: challenges and opportunities during drug development.
Yáñez JA; Remsberg CM; Sayre CL; Forrest ML; Davies NM
Ther Deliv; 2011 May; 2(5):643-72. PubMed ID: 21837267
[TBL] [Abstract][Full Text] [Related]
8. A reversible clearance model for the enterohepatic circulation of drug and conjugate metabolite pair.
Semmes RL; Shen DD
Drug Metab Dispos; 1990; 18(1):80-7. PubMed ID: 1970782
[TBL] [Abstract][Full Text] [Related]
9. PBPK models for the prediction of in vivo performance of oral dosage forms.
Kostewicz ES; Aarons L; Bergstrand M; Bolger MB; Galetin A; Hatley O; Jamei M; Lloyd R; Pepin X; Rostami-Hodjegan A; Sjögren E; Tannergren C; Turner DB; Wagner C; Weitschies W; Dressman J
Eur J Pharm Sci; 2014 Jun; 57():300-21. PubMed ID: 24060672
[TBL] [Abstract][Full Text] [Related]
10. Bile salts and their importance for drug absorption.
Holm R; Müllertz A; Mu H
Int J Pharm; 2013 Aug; 453(1):44-55. PubMed ID: 23598075
[TBL] [Abstract][Full Text] [Related]
11. Enteric reabsorption processes and their impact on drug pharmacokinetics.
Ibarra M; Trocóniz IF; Fagiolino P
Sci Rep; 2021 Mar; 11(1):5794. PubMed ID: 33707635
[TBL] [Abstract][Full Text] [Related]
12. In silico predictions of gastrointestinal drug absorption in pharmaceutical product development: application of the mechanistic absorption model GI-Sim.
Sjögren E; Westergren J; Grant I; Hanisch G; Lindfors L; Lennernäs H; Abrahamsson B; Tannergren C
Eur J Pharm Sci; 2013 Jul; 49(4):679-98. PubMed ID: 23727464
[TBL] [Abstract][Full Text] [Related]
13. Insights from pharmacokinetic models of host-microbiome drug metabolism.
Zimmermann-Kogadeeva M; Zimmermann M; Goodman AL
Gut Microbes; 2020 May; 11(3):587-596. PubMed ID: 31564204
[TBL] [Abstract][Full Text] [Related]
14. Exploitation of bile acid transport systems in prodrug design.
Sievänen E
Molecules; 2007 Aug; 12(8):1859-89. PubMed ID: 17960093
[TBL] [Abstract][Full Text] [Related]
15. Analysis of the Change in the Blood Concentration-Time Profile Caused by Complex Drug-Drug Interactions in the Liver Considering the Enterohepatic Circulation: Examining Whether the Inhibition Constants for Uptake, Metabolism, and Biliary Excretion Can be Recovered by the Analyses Using Physiologically Based Pharmacokinetic Modeling.
Toshimoto K; Tomoda Y; Chiba K; Sugiyama Y
J Pharm Sci; 2017 Sep; 106(9):2727-2738. PubMed ID: 28479365
[TBL] [Abstract][Full Text] [Related]
16. Biliary excretion of drugs and other xenobiotics.
Levine WG
Annu Rev Pharmacol Toxicol; 1978; 18():81-96. PubMed ID: 348071
[TBL] [Abstract][Full Text] [Related]
17. Transport of organic cationic drugs: effect of ion-pair formation with bile salts on the biliary excretion and pharmacokinetics.
Song IS; Choi MK; Shim WS; Shim CK
Pharmacol Ther; 2013 Apr; 138(1):142-54. PubMed ID: 23353097
[TBL] [Abstract][Full Text] [Related]
18. Pharmacokinetic simulation of biowaiver criteria: the effects of gastric emptying, dissolution, absorption and elimination rates.
Kortejärvi H; Urtti A; Yliperttula M
Eur J Pharm Sci; 2007 Feb; 30(2):155-66. PubMed ID: 17187967
[TBL] [Abstract][Full Text] [Related]
19. Ontogeny of oral drug absorption processes in children.
Mooij MG; de Koning BA; Huijsman ML; de Wildt SN
Expert Opin Drug Metab Toxicol; 2012 Oct; 8(10):1293-303. PubMed ID: 22686526
[TBL] [Abstract][Full Text] [Related]
20. Description and simulation of a physiological pharmacokinetic model for the metabolism and enterohepatic circulation of bile acids in man. Cholic acid in healthy man.
Hofmann AF; Molino G; Milanese M; Belforte G
J Clin Invest; 1983 Apr; 71(4):1003-22. PubMed ID: 6682120
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
